LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
---|---|---|---|---|---|---|---|---|
MDA-MB-231 | JW-7-24-1 | 0.37 | uM | LJP6 | 0.7717 | 0.0405 | 0.6915 | 0.0525 |
MDA-MB-231 | Lapatinib | 0.37 | uM | LJP6 | 0.9503 | 0.0057 | 0.9325 | 0.0083 |
MDA-MB-231 | LDN-193189 | 0.37 | uM | LJP5 | 0.9371 | 0.0236 | 0.9142 | 0.0326 |
MDA-MB-231 | Linifanib | 0.37 | uM | LJP6 | 1.0717 | 0.0433 | 1.0961 | 0.0573 |
MDA-MB-231 | Linsitinib | 0.37 | uM | LJP5 | 0.8779 | 0.0463 | 0.8348 | 0.0625 |
MDA-MB-231 | Mitoxantrone | 0.37 | uM | LJP5 | 0.2005 | 0.0187 | -0.0833 | 0.0359 |
MDA-MB-231 | Mitoxantrone | 0.37 | uM | LJP6 | 0.1962 | 0.0243 | -0.0892 | 0.0435 |
MDA-MB-231 | MK2206 | 0.37 | uM | LJP6 | 0.8278 | 0.0196 | 0.7672 | 0.0242 |
MDA-MB-231 | Neratinib | 0.37 | uM | LJP5 | 0.7611 | 0.0704 | 0.6776 | 0.0925 |
MDA-MB-231 | Nilotinib | 0.37 | uM | LJP5 | 0.8826 | 0.0660 | 0.8425 | 0.0873 |
MDA-MB-231 | Nintedanib | 0.37 | uM | LJP6 | 0.9854 | 0.0098 | 0.9800 | 0.0133 |
MDA-MB-231 | NU7441 | 0.37 | uM | LJP5 | 0.9062 | 0.0597 | 0.8745 | 0.0796 |
MDA-MB-231 | Dactolisib | 0.37 | uM | LJP5 | 0.3754 | 0.0575 | 0.1526 | 0.0862 |
MDA-MB-231 | NVP-TAE684 | 0.37 | uM | LJP6 | 0.7232 | 0.0404 | 0.6244 | 0.0579 |
MDA-MB-231 | Palbociclib | 0.37 | uM | LJP6 | 0.5558 | 0.0277 | 0.3980 | 0.0419 |
MDA-MB-231 | PD0325901 | 0.37 | uM | LJP5 | 0.4224 | 0.0075 | 0.2176 | 0.0156 |
MDA-MB-231 | PD0325901 | 0.37 | uM | LJP6 | 0.4024 | 0.0045 | 0.1907 | 0.0094 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 1.0638 | 0.0307 | 1.0872 | 0.0427 |
MDA-MB-231 | PD184352 | 0.37 | uM | LJP5 | 0.7954 | 0.0258 | 0.7236 | 0.0323 |
MDA-MB-231 | Pelitinib | 0.37 | uM | LJP5 | 0.8948 | 0.0362 | 0.8584 | 0.0474 |
MDA-MB-231 | PF431396 | 0.37 | uM | LJP5 | 0.5733 | 0.0747 | 0.4205 | 0.1068 |
MDA-MB-231 | PF477736 | 0.37 | uM | LJP5 | 0.7793 | 0.0671 | 0.7005 | 0.0924 |
MDA-MB-231 | PF562271 | 0.37 | uM | LJP6 | 0.7630 | 0.0365 | 0.6782 | 0.0526 |
MDA-MB-231 | PHA-665752 | 0.37 | uM | LJP5 | 1.0290 | 0.0158 | 1.0393 | 0.0215 |
MDA-MB-231 | PHA-793887 | 0.37 | uM | LJP6 | 0.2790 | 0.0109 | 0.0234 | 0.0222 |